{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T16:36:27Z","timestamp":1773678987339,"version":"3.50.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"15-16","license":[{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T00:00:00Z","timestamp":1648425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100022308","name":"Karl Landsteiner Privatuniversit\u00e4t f\u00fcr Gesundheitswissenschaften","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100022308","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Optical coherence tomography (OCT) is of increasing interest in the clinical assessment of multiple sclerosis (MS) patients beyond the scope of clinical studies. In this narrative review, we discuss novel changes of OCT parameters during acute optic neuritis and the disease course of MS patients. OCT images document the changes of retinal layers during an episode of acute optic neuritis and can therefore provide valuable insights into the pathophysiology. Moreover, MS patients show progredient thinning of retinal layers throughout the disease. The thinning is accelerated through relapses as well as disease progression without relapse. The OCT parameters are also associated with clinical outcome parameters, including disability, cognitive function, and brain atrophy. The impact of disease-modifying therapies on OCT parameters is the subject of ongoing research and depends on the agent used. Additional data are still necessary before OCT parameters can be implemented in the clinical standard of care of MS patients.<\/jats:p>","DOI":"10.1007\/s10354-022-00925-2","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T04:32:33Z","timestamp":1648528353000},"page":"329-336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Retinal imaging with optical coherence tomography in multiple sclerosis: novel aspects","Retinale Bildgebung mittels optischer Koh\u00e4renztomographie bei multipler Sklerose: neue Aspekte"],"prefix":"10.1007","volume":"172","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0300-2031","authenticated-orcid":false,"given":"Elisabeth","family":"Olbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Struhal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,28]]},"reference":[{"key":"925_CR1","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1126\/science.1957169","volume":"254","author":"D Huang","year":"1991","unstructured":"Huang\u00a0D, Swanson\u00a0EA, Lin\u00a0CP, et\u00a0al. Optical coherence tomography. Science. 1991;254:1178\u201381.","journal-title":"Science"},{"key":"925_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ajo.2009.08.037","volume":"149","author":"DF Kiernan","year":"2010","unstructured":"Kiernan\u00a0DF, Mieler\u00a0WF, Hariprasad\u00a0SM. Spectral-domain optical coherence tomography: a\u00a0comparison of modern high-resolution retinal imaging systems. Am J Ophthalmol. 2010;149:18\u201331. https:\/\/doi.org\/10.1016\/j.ajo.2009.08.037.","journal-title":"Am J Ophthalmol"},{"key":"925_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-3-030-16638-0_3","volume-title":"High resolution imaging in microscopy and ophthalmology: new frontiers in biomedical optics","author":"S Aumann","year":"2019","unstructured":"Aumann\u00a0S, Donner\u00a0S, Fischer\u00a0J, et\u00a0al. Optical coherence tomography (OCT): principle and technical realization. In: Bille\u00a0JF, editor. High resolution imaging in microscopy and ophthalmology: new frontiers in biomedical optics. Cham: Springer; 2019. pp.\u00a059\u201385."},{"key":"925_CR4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s11910-018-0911-x","volume":"18","author":"A Wyl\u0119ga\u0142a","year":"2018","unstructured":"Wyl\u0119ga\u0142a\u00a0A. Principles of OCTA and applications in clinical neurology. Curr Neurol Neurosci Rep. 2018;18:96. https:\/\/doi.org\/10.1007\/s11910-018-0911-x.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"925_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.11.003","volume":"64","author":"RF Spaide","year":"2018","unstructured":"Spaide\u00a0RF, Fujimoto\u00a0JG, Waheed\u00a0NK, et\u00a0al. Optical coherence tomography angiography. Prog Retin Eye Res. 2018;64:1\u201355. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.11.003.","journal-title":"Prog Retin Eye Res"},{"key":"925_CR6","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000012125","author":"A Aytulun","year":"2021","unstructured":"Aytulun\u00a0A, Cruz-Herranz\u00a0A, Aktas\u00a0O, et al. The APOSTEL 2.0 recommendations for reporting quantitative optical coherence tomography studies. Neurology. 2021; https:\/\/doi.org\/10.1212\/wnl.0000000000012125.","journal-title":"Neurology"},{"key":"925_CR7","doi-asserted-by":"publisher","first-page":"101856","DOI":"10.1016\/j.media.2020.101856","volume":"68","author":"Y He","year":"2021","unstructured":"He\u00a0Y, Carass\u00a0A, Liu\u00a0Y, et\u00a0al. Structured layer surface segmentation for retina OCT using fully convolutional regression networks. Med Image Anal. 2021;68:101856. https:\/\/doi.org\/10.1016\/j.media.2020.101856.","journal-title":"Med Image Anal"},{"key":"925_CR8","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/978-3-030-32239-7_14","volume":"11764","author":"Y He","year":"2019","unstructured":"He\u00a0Y, Carass\u00a0A, Liu\u00a0Y, et\u00a0al. Fully convolutional boundary regression for retina OCT segmentation. Med Image Comput Comput Assist Interv. 2019;11764:120\u20138. https:\/\/doi.org\/10.1007\/978-3-030-32239-7_14.","journal-title":"Med Image Comput Comput Assist Interv"},{"key":"925_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51320","author":"A Petzold","year":"2021","unstructured":"Petzold\u00a0A, Albrecht\u00a0P, Balcer\u00a0L, et al. Artificial intelligence extension of the OSCAR-IB criteria. Ann Clin Transl Neurol. 2021; https:\/\/doi.org\/10.1002\/acn3.51320.","journal-title":"Ann Clin Transl Neurol"},{"key":"925_CR10","doi-asserted-by":"publisher","first-page":"e34823","DOI":"10.1371\/journal.pone.0034823","volume":"7","author":"P Tewarie","year":"2012","unstructured":"Tewarie\u00a0P, Balk\u00a0L, Costello\u00a0F, et al. The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS One. 2012;7:e34823. https:\/\/doi.org\/10.1371\/journal.pone.0034823.","journal-title":"PLoS One"},{"key":"925_CR11","doi-asserted-by":"publisher","first-page":"42201","DOI":"10.1038\/srep42201","volume":"7","author":"JP Campbell","year":"2017","unstructured":"Campbell\u00a0JP, Zhang\u00a0M, Hwang\u00a0TS, et al. Detailed vascular anatomy of the human retina by projection-resolved optical coherence tomography angiography. Sci Rep. 2017;7:42201. https:\/\/doi.org\/10.1038\/srep42201.","journal-title":"Sci Rep"},{"key":"925_CR12","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.24351","volume":"77","author":"I Gabilondo","year":"2015","unstructured":"Gabilondo\u00a0I, Martinez-Lapiscina\u00a0EH, Fraga-Pumar\u00a0E, et al. Dynamics of retinal injury after acute optic neuritis. Ann Neurol. 2015;77:517\u201328. https:\/\/doi.org\/10.1002\/ana.24351.","journal-title":"Ann Neurol"},{"key":"925_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2147\/eb.S295610","volume":"13","author":"N Schurz","year":"2021","unstructured":"Schurz\u00a0N, Sariaslani\u00a0L, Altmann\u00a0P, et al. Evaluation of retinal layer thickness parameters as biomarkers in a\u00a0real-world multiple sclerosis cohort. Eye Brain. 2021;13:59\u201369. https:\/\/doi.org\/10.2147\/eb.S295610.","journal-title":"Eye Brain"},{"key":"925_CR14","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1093\/brain\/awaa458","volume":"144","author":"M Pisa","year":"2021","unstructured":"Pisa\u00a0M, Croese\u00a0T, Dalla Costa\u00a0G, et\u00a0al. Subclinical anterior optic pathway involvement in early multiple sclerosis and clinically isolated syndromes. Brain. 2021;144:848\u201362. https:\/\/doi.org\/10.1093\/brain\/awaa458.","journal-title":"Brain"},{"key":"925_CR15","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3389\/fneur.2020.00858","volume":"11","author":"L Ziccardi","year":"2020","unstructured":"Ziccardi\u00a0L, Barbano\u00a0L, Boffa\u00a0L, et\u00a0al. Morphological outer retina findings in multiple sclerosis patients with or without optic neuritis. Front Neurol. 2020;11:858. https:\/\/doi.org\/10.3389\/fneur.2020.00858.","journal-title":"Front Neurol"},{"key":"925_CR16","doi-asserted-by":"publisher","first-page":"e1130","DOI":"10.1212\/wnl.0000000000006207","volume":"91","author":"WJ Brownlee","year":"2018","unstructured":"Brownlee\u00a0WJ, Miszkiel\u00a0KA, Tur\u00a0C, et\u00a0al. Inclusion of optic nerve involvement in dissemination in space criteria for multiple sclerosis. Neurology. 2018;91:e1130\u2013e4. https:\/\/doi.org\/10.1212\/wnl.0000000000006207.","journal-title":"Neurology"},{"key":"925_CR17","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00115-021-01157-2","volume":"92","author":"H Wiendl","year":"2021","unstructured":"Wiendl\u00a0H, Gold\u00a0R, Berger\u00a0T, et al. Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper). Nervenarzt. 2021;92:773\u2013801. https:\/\/doi.org\/10.1007\/s00115-021-01157-2.","journal-title":"Nervenarzt"},{"key":"925_CR18","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/ana.25462","volume":"85","author":"RC Nolan-Kenney","year":"2019","unstructured":"Nolan-Kenney\u00a0RC, Liu\u00a0M, Akhand\u00a0O, et al. Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: an international study. Ann Neurol. 2019;85:618\u201329. https:\/\/doi.org\/10.1002\/ana.25462.","journal-title":"Ann Neurol"},{"key":"925_CR19","doi-asserted-by":"publisher","first-page":"102403","DOI":"10.1016\/j.msard.2020.102403","volume":"45","author":"G Bsteh","year":"2020","unstructured":"Bsteh\u00a0G, Hegen\u00a0H, Altmann\u00a0P, et al. Validation of inter-eye difference thresholds in optical coherence tomography for identification of optic neuritis in multiple sclerosis. Mult Scler Relat Disord. 2020;45:102403. https:\/\/doi.org\/10.1016\/j.msard.2020.102403.","journal-title":"Mult Scler Relat Disord"},{"key":"925_CR20","doi-asserted-by":"publisher","first-page":"101988","DOI":"10.1016\/j.msard.2020.101988","volume":"41","author":"R Behbehani","year":"2020","unstructured":"Behbehani\u00a0R, Ali\u00a0A, Al-Omairah\u00a0H, et al. Optimization of spectral domain optical coherence tomography and visual evoked potentials to identify unilateral optic neuritis. Mult Scler Relat Disord. 2020;41:101988. https:\/\/doi.org\/10.1016\/j.msard.2020.101988.","journal-title":"Mult Scler Relat Disord"},{"key":"925_CR21","doi-asserted-by":"publisher","first-page":"e733","DOI":"10.1212\/wnl.0000000000009832","volume":"95","author":"O Outteryck","year":"2020","unstructured":"Outteryck\u00a0O, Lopes\u00a0R, Drumez \u00c9, et\u00a0al. Optical coherence tomography for detection of asymptomatic optic nerve lesions in clinically isolated syndrome. Neurology. 2020;95:e733\u2013e44. https:\/\/doi.org\/10.1212\/wnl.0000000000009832.","journal-title":"Neurology"},{"key":"925_CR22","doi-asserted-by":"publisher","first-page":"e2468","DOI":"10.1212\/wnl.0000000000009504","volume":"94","author":"JB Davion","year":"2020","unstructured":"Davion\u00a0JB, Lopes\u00a0R, Drumez \u00c9, et\u00a0al. Asymptomatic optic nerve lesions: an underestimated cause of silent retinal atrophy in MS. Neurology. 2020;94:e2468\u2013e78. https:\/\/doi.org\/10.1212\/wnl.0000000000009504.","journal-title":"Neurology"},{"key":"925_CR23","doi-asserted-by":"publisher","DOI":"10.1177\/1120672121996638","author":"KT \u00d6zbilen","year":"2021","unstructured":"\u00d6zbilen\u00a0KT, G\u00fcnd\u00fcz\u00a0T, \u00c7ukurova Kartal\u00a0SN, et al. Bruch\u2019s membrane opening-minimum rim width: an alternative OCT biomarker study for multiple sclerosis. Eur J Ophthalmol. 2021; https:\/\/doi.org\/10.1177\/1120672121996638.","journal-title":"Eur J Ophthalmol"},{"key":"925_CR24","doi-asserted-by":"publisher","first-page":"330","DOI":"10.5222\/mmj.2020.99075","volume":"35","author":"S Balci","year":"2020","unstructured":"Balci\u00a0S, Yildiz\u00a0MB, Ozcelik Kose\u00a0A, et\u00a0al. Optic nerve head changes in patients with optic neuritis secondary to multiple sclerosis: a comparison of the affected and fellow healthy eyes. Medeni Med\u00a0J. 2020;35:330\u20137. https:\/\/doi.org\/10.5222\/mmj.2020.99075.","journal-title":"Medeni Med J"},{"key":"925_CR25","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000000665","author":"M Pawlitzki","year":"2020","unstructured":"Pawlitzki\u00a0M, Horbr\u00fcgger\u00a0M, Loewe\u00a0K, et al. MS optic neuritis-induced long-term structural changes within the visual pathway. Neurol Neuroimmunol Neuroinflamm. 2020; https:\/\/doi.org\/10.1212\/nxi.0000000000000665.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"925_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10132892","author":"\u0141 Rzepi\u0144ski","year":"2021","unstructured":"Rzepi\u0144ski \u0141, Kucharczuk\u00a0J, Maciejek\u00a0Z, et al. Spectral-domain optical coherence tomography assessment in treatment-na\u00efve patients with clinically isolated syndrome and different multiple sclerosis types: findings and relationship with the disability status. J\u00a0Clin Med. 2021; https:\/\/doi.org\/10.3390\/jcm10132892.","journal-title":"J Clin Med"},{"key":"925_CR27","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000000671","author":"CA Wicki","year":"2020","unstructured":"Wicki\u00a0CA, Manogaran\u00a0P, Simic\u00a0T, et al. Bilateral retinal pathology following a\u00a0first-ever clinical episode of autoimmune optic neuritis. Neurol Neuroimmunol Neuroinflamm. 2020; https:\/\/doi.org\/10.1212\/nxi.0000000000000671.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"925_CR28","doi-asserted-by":"publisher","first-page":"5573839","DOI":"10.1155\/2021\/5573839","volume":"2021","author":"R Estiasari","year":"2021","unstructured":"Estiasari\u00a0R, Diwyacitta\u00a0A, Sidik\u00a0M, et al. Evaluation of retinal structure and optic nerve function changes in multiple sclerosis: longitudinal study with 1\u2011year follow-up. Neurol Res Int. 2021;2021:5573839. https:\/\/doi.org\/10.1155\/2021\/5573839.","journal-title":"Neurol Res Int"},{"key":"925_CR29","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1167\/iovs.15-19047","volume":"57","author":"EC Graham","year":"2016","unstructured":"Graham\u00a0EC, You\u00a0Y, Yiannikas\u00a0C, et\u00a0al. Progressive loss of retinal ganglion cells and axons in nonoptic neuritis eyes in multiple sclerosis: a longitudinal optical coherence tomography study. Invest Ophthalmol Vis Sci. 2016;57:2311\u20137. https:\/\/doi.org\/10.1167\/iovs.15-19047.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"925_CR30","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/s1474-4422(17)30278-8","volume":"16","author":"A Petzold","year":"2017","unstructured":"Petzold\u00a0A, Balcer\u00a0LJ, Calabresi\u00a0PA, et al. Retinal layer segmentation in multiple sclerosis: a\u00a0systematic review and meta-analysis. Lancet Neurol. 2017;16:797\u2013812. https:\/\/doi.org\/10.1016\/s1474-4422(17)30278-8.","journal-title":"Lancet Neurol"},{"key":"925_CR31","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/s1474-4422(10)70168-x","volume":"9","author":"A Petzold","year":"2010","unstructured":"Petzold\u00a0A, de Boer\u00a0JF, Schippling\u00a0S, et al. Optical coherence tomography in multiple sclerosis: a\u00a0systematic review and meta-analysis. Lancet Neurol. 2010;9:921\u201332. https:\/\/doi.org\/10.1016\/s1474-4422(10)70168-x.","journal-title":"Lancet Neurol"},{"key":"925_CR32","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/brain\/awq080","volume":"133","author":"AJ Green","year":"2010","unstructured":"Green\u00a0AJ, McQuaid\u00a0S, Hauser\u00a0SL, et\u00a0al. Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain. 2010;133:1591\u2013601. https:\/\/doi.org\/10.1093\/brain\/awq080.","journal-title":"Brain"},{"key":"925_CR33","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000076892","volume":"36","author":"WA Gorczyca","year":"2004","unstructured":"Gorczyca\u00a0WA, Ejma\u00a0M, Witkowska\u00a0D, et\u00a0al. Retinal antigens are recognized by antibodies present in sera of patients with multiple sclerosis. Ophthalmic Res. 2004;36:120\u20133. https:\/\/doi.org\/10.1159\/000076892.","journal-title":"Ophthalmic Res"},{"key":"925_CR34","doi-asserted-by":"publisher","first-page":"e0183957","DOI":"10.1371\/journal.pone.0183957","volume":"12","author":"M Puthenparampil","year":"2017","unstructured":"Puthenparampil\u00a0M, Federle\u00a0L, Poggiali\u00a0D, et al. Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis. PLoS One. 2017;12:e183957. https:\/\/doi.org\/10.1371\/journal.pone.0183957.","journal-title":"PLoS One"},{"key":"925_CR35","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/s41433-017-0010-2","volume":"32","author":"J Britze","year":"2018","unstructured":"Britze\u00a0J, Frederiksen\u00a0JL. Optical coherence tomography in multiple sclerosis. Eye (Lond). 2018;32:884\u20138. https:\/\/doi.org\/10.1038\/s41433-017-0010-2.","journal-title":"Eye (Lond)"},{"key":"925_CR36","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1177\/1352458520917924","volume":"27","author":"G Pihl-Jensen","year":"2021","unstructured":"Pihl-Jensen\u00a0G, Wanscher\u00a0B, Frederiksen\u00a0JL. Predictive value of optical coherence tomography, multifocal visual evoked potentials, and full-field visual evoked potentials of the fellow, non-symptomatic eye for subsequent multiple sclerosis development in patients with acute optic neuritis. Mult Scler. 2021;27:391\u2013400. https:\/\/doi.org\/10.1177\/1352458520917924.","journal-title":"Mult Scler"},{"key":"925_CR37","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1111\/ene.14416","volume":"27","author":"L Aly","year":"2020","unstructured":"Aly\u00a0L, Havla\u00a0J, Lepennetier\u00a0G, et\u00a0al. Inner retinal layer thinning in radiologically isolated syndrome predicts conversion to multiple sclerosis. Eur J Neurol. 2020;27:2217\u201324. https:\/\/doi.org\/10.1111\/ene.14416.","journal-title":"Eur J Neurol"},{"key":"925_CR38","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1159\/000510116","volume":"83","author":"V Cilingir","year":"2020","unstructured":"Cilingir\u00a0V, Batur\u00a0M. Axonal degeneration independent of inflammatory activity: is it more intense in the early stages of relapsing-remitting multiple sclerosis disease? Eur Neurol. 2020;83:508\u201316. https:\/\/doi.org\/10.1159\/000510116.","journal-title":"Eur Neurol"},{"key":"925_CR39","doi-asserted-by":"publisher","first-page":"13333","DOI":"10.1038\/s41598-020-70255-z","volume":"10","author":"I Pulido-Valdeolivas","year":"2020","unstructured":"Pulido-Valdeolivas\u00a0I, Andorr\u00e0\u00a0M, G\u00f3mez-Andr\u00e9s\u00a0D, et al. Retinal and brain damage during multiple sclerosis course: inflammatory activity is a\u00a0key factor in the first 5\u00a0years. Sci Rep. 2020;10:13333. https:\/\/doi.org\/10.1038\/s41598-020-70255-z.","journal-title":"Sci Rep"},{"key":"925_CR40","doi-asserted-by":"publisher","first-page":"205521732096634","DOI":"10.1177\/2055217320966344","volume":"6","author":"G Bsteh","year":"2020","unstructured":"Bsteh\u00a0G, Hegen\u00a0H, Altmann\u00a0P, et\u00a0al. Retinal layer thinning is reflecting disability progression independent of relapse activity in multiple sclerosis. Mult Scler J Exp Transl Clin. 2020;6:2055217320966344. https:\/\/doi.org\/10.1177\/2055217320966344.","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"925_CR41","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/ana.25738","volume":"87","author":"ES Sotirchos","year":"2020","unstructured":"Sotirchos\u00a0ES, Gonzalez Caldito\u00a0N, Filippatou\u00a0A, et\u00a0al. Progressive multiple sclerosis is associated with faster and specific retinal layer atrophy. Ann Neurol. 2020;87:885\u201396. https:\/\/doi.org\/10.1002\/ana.25738.","journal-title":"Ann Neurol"},{"key":"925_CR42","doi-asserted-by":"publisher","first-page":"117552","DOI":"10.1016\/j.jns.2021.117552","volume":"427","author":"D Jakimovski","year":"2021","unstructured":"Jakimovski\u00a0D, Zivadinov\u00a0R, Vaughn\u00a0CB, et al. Clinical effects associated with five-year retinal nerve fiber layer thinning in multiple sclerosis. J\u00a0Neurol Sci. 2021;427:117552. https:\/\/doi.org\/10.1016\/j.jns.2021.117552.","journal-title":"J Neurol Sci"},{"key":"925_CR43","doi-asserted-by":"publisher","DOI":"10.1097\/wno.0000000000001165","author":"M Cellerino","year":"2020","unstructured":"Cellerino\u00a0M, Priano\u00a0L, Bruschi\u00a0N, et al. Relationship between retinal layers thickness and disability worsening in relapsing-remitting and progressive multiple sclerosis. J\u00a0Neuroophthalmol. 2020; https:\/\/doi.org\/10.1097\/wno.0000000000001165.","journal-title":"J Neuroophthalmol"},{"key":"925_CR44","doi-asserted-by":"publisher","first-page":"117180","DOI":"10.1016\/j.jns.2020.117180","volume":"419","author":"A Barreiro-Gonz\u00e1lez","year":"2020","unstructured":"Barreiro-Gonz\u00e1lez\u00a0A, Sanz\u00a0MT, Carratal\u00e0-Bosc\u00e0\u00a0S, et al. Magnetic resonance imaging and optical coherence tomography correlations in multiple sclerosis beyond anatomical landmarks. J\u00a0Neurol Sci. 2020;419:117180. https:\/\/doi.org\/10.1016\/j.jns.2020.117180.","journal-title":"J Neurol Sci"},{"key":"925_CR45","doi-asserted-by":"publisher","DOI":"10.1177\/13524585211023343","author":"R Mizell","year":"2021","unstructured":"Mizell\u00a0R, Chen\u00a0H, Lambe\u00a0J, et\u00a0al. Association of retinal atrophy with cortical lesions and leptomeningeal enhancement in multiple sclerosis on 7T MRI. Mult Scler. 2021; https:\/\/doi.org\/10.1177\/13524585211023343.","journal-title":"Mult Scler"},{"key":"925_CR46","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/ane.13282","volume":"142","author":"M Borgstr\u00f6m","year":"2020","unstructured":"Borgstr\u00f6m\u00a0M, Tisell\u00a0A, Link\u00a0H, et\u00a0al. Retinal thinning and brain atrophy in early MS and CIS. Acta Neurol Scand. 2020;142:418\u201327. https:\/\/doi.org\/10.1111\/ane.13282.","journal-title":"Acta Neurol Scand"},{"key":"925_CR47","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1111\/ene.14421","volume":"27","author":"A Vidal-Jordana","year":"2020","unstructured":"Vidal-Jordana\u00a0A, Pareto\u00a0D, Cabello\u00a0S, et al. Optical coherence tomography measures correlate with brain and spinal cord atrophy and multiple sclerosis disease-related disability. Eur J Neurol. 2020;27:2225\u201332. https:\/\/doi.org\/10.1111\/ene.14421.","journal-title":"Eur J Neurol"},{"key":"925_CR48","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1177\/1352458517740216","volume":"25","author":"G Bsteh","year":"2019","unstructured":"Bsteh\u00a0G, Hegen\u00a0H, Teuchner\u00a0B, et\u00a0al. Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a\u00a0prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis. Mult Scler. 2019;25:196\u2013203. https:\/\/doi.org\/10.1177\/1352458517740216.","journal-title":"Mult Scler"},{"key":"925_CR49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.29399\/npa.27355","volume":"58","author":"C Uzunk\u00f6pr\u00fc","year":"2021","unstructured":"Uzunk\u00f6pr\u00fc\u00a0C, Y\u00fcceyar\u00a0N, Yilmaz\u00a0SG, et\u00a0al. Retinal nerve fiber layer thickness correlates with serum and cerebrospinal fluid neurofilament levels and is associated with current disability in multiple sclerosis. Noro Psikiyatr Ars. 2021;58:34\u201340. https:\/\/doi.org\/10.29399\/npa.27355.","journal-title":"Noro Psikiyatr Ars"},{"key":"925_CR50","doi-asserted-by":"publisher","first-page":"175628642110034","DOI":"10.1177\/17562864211003478","volume":"14","author":"CB Seitz","year":"2021","unstructured":"Seitz\u00a0CB, Steffen\u00a0F, Muthuraman\u00a0M, et\u00a0al. Serum neurofilament levels reflect outer retinal layer changes in multiple sclerosis. Ther Adv Neurol Disord. 2021;14:17562864211003478. https:\/\/doi.org\/10.1177\/17562864211003478.","journal-title":"Ther Adv Neurol Disord"},{"key":"925_CR51","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1007\/s10072-020-04431-4","volume":"41","author":"AM Pietroboni","year":"2020","unstructured":"Pietroboni\u00a0AM, Carandini\u00a0T, Dell\u2019Arti\u00a0L, et\u00a0al. Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis: a\u00a0longitudinal OCT study. Neurol Sci. 2020;41:3175\u201383. https:\/\/doi.org\/10.1007\/s10072-020-04431-4.","journal-title":"Neurol Sci"},{"key":"925_CR52","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1177\/1352458520935724","volume":"27","author":"G Bsteh","year":"2021","unstructured":"Bsteh\u00a0G, Berek\u00a0K, Hegen\u00a0H, et al. Macular ganglion cell-inner plexiform layer thinning as a\u00a0biomarker of disability progression in relapsing multiple sclerosis. Mult Scler. 2021;27:684\u201394. https:\/\/doi.org\/10.1177\/1352458520935724.","journal-title":"Mult Scler"},{"key":"925_CR53","doi-asserted-by":"publisher","first-page":"e2058","DOI":"10.1212\/wnl.0000000000011788","volume":"96","author":"J Lambe","year":"2021","unstructured":"Lambe\u00a0J, Fitzgerald\u00a0KC, Murphy\u00a0OC, et al. Association of spectral-domain OCT with long-term disability worsening in multiple sclerosis. Neurology. 2021;96:e2058\u2013e69. https:\/\/doi.org\/10.1212\/wnl.0000000000011788.","journal-title":"Neurology"},{"key":"925_CR54","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1007\/s00415-021-10437-5","volume":"268","author":"D Jakimovski","year":"2021","unstructured":"Jakimovski\u00a0D, Benedict\u00a0RHB, Weinstock-Guttman\u00a0B, et al. Visual deficits and cognitive assessment of multiple sclerosis: confounder, correlate, or both? J\u00a0Neurol. 2021;268:2578\u201388. https:\/\/doi.org\/10.1007\/s00415-021-10437-5.","journal-title":"J Neurol"},{"key":"925_CR55","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1080\/01616412.2020.1761174","volume":"42","author":"A Esmael","year":"2020","unstructured":"Esmael\u00a0A, Elsherif\u00a0M, Abdelsalam\u00a0M, et\u00a0al. Retinal thickness as a\u00a0potential biomarker of neurodegeneration and a\u00a0predictor of early cognitive impairment in patients with multiple sclerosis. Neurol Res. 2020;42:564\u201374. https:\/\/doi.org\/10.1080\/01616412.2020.1761174.","journal-title":"Neurol Res"},{"key":"925_CR56","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000001018","author":"SJ Baetge","year":"2021","unstructured":"Baetge\u00a0SJ, Dietrich\u00a0M, Filser\u00a0M, et\u00a0al. Association of retinal layer thickness with cognition in patients with multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2021; https:\/\/doi.org\/10.1212\/nxi.0000000000001018.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"925_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10469-x","author":"V Cilingir","year":"2021","unstructured":"Cilingir\u00a0V, Batur\u00a0M. First measured retinal nerve fiber layer thickness in RRMS can be used as a\u00a0biomarker for the course of the disease: threshold value discussions. J\u00a0Neurol. 2021; https:\/\/doi.org\/10.1007\/s00415-021-10469-x.","journal-title":"J Neurol"},{"key":"925_CR58","doi-asserted-by":"publisher","first-page":"104416","DOI":"10.1016\/j.compbiomed.2021.104416","volume":"133","author":"A Montol\u00edo","year":"2021","unstructured":"Montol\u00edo\u00a0A, Mart\u00edn-Gallego\u00a0A, Cego\u00f1ino\u00a0J, et al. Machine learning in diagnosis and disability prediction of multiple sclerosis using optical coherence tomography. Comput Biol Med. 2021;133:104416. https:\/\/doi.org\/10.1016\/j.compbiomed.2021.104416.","journal-title":"Comput Biol Med"},{"key":"925_CR59","doi-asserted-by":"publisher","first-page":"53","DOI":"10.7224\/1537-2073.2020-005","volume":"23","author":"JR Abbatemarco","year":"2021","unstructured":"Abbatemarco\u00a0JR, Fox\u00a0RJ, Li\u00a0H, et al. Vitamin D levels and visual system measurements in progressive multiple sclerosis: a cross-sectional study. Int J MS Care. 2021;23:53\u20138. https:\/\/doi.org\/10.7224\/1537-2073.2020-005.","journal-title":"Int J MS Care"},{"key":"925_CR60","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1177\/1352458519900942","volume":"26","author":"AG Filippatou","year":"2020","unstructured":"Filippatou\u00a0AG, Lambe\u00a0J, Sotirchos\u00a0ES, et\u00a0al. Association of body mass index with longitudinal rates of retinal atrophy in multiple sclerosis. Mult Scler. 2020;26:843\u201354. https:\/\/doi.org\/10.1177\/1352458519900942.","journal-title":"Mult Scler"},{"key":"925_CR61","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/ana.25782","volume":"88","author":"A Petzold","year":"2020","unstructured":"Petzold\u00a0A, Coric\u00a0D, Balk\u00a0LJ, et al. Longitudinal development of peripapillary hyper-reflective ovoid masslike structures suggests a\u00a0novel pathological pathway in multiple sclerosis. Ann Neurol. 2020;88:309\u201319. https:\/\/doi.org\/10.1002\/ana.25782.","journal-title":"Ann Neurol"},{"key":"925_CR62","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41433-020-0890-4","volume":"35","author":"E Borrelli","year":"2021","unstructured":"Borrelli\u00a0E, Barboni\u00a0P, Battista\u00a0M, et al. Peripapillary hyperreflective ovoid mass-like structures (PHOMS): OCTA may reveal new findings. Eye (Lond). 2021;35:528\u201331. https:\/\/doi.org\/10.1038\/s41433-020-0890-4.","journal-title":"Eye (Lond)"},{"key":"925_CR63","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15056","author":"R Wicklein","year":"2021","unstructured":"Wicklein\u00a0R, Wauschkuhn\u00a0J, Giglhuber\u00a0K, et al. Association of peripapillary hyper-reflective ovoid masslike structures and disease duration in primary progressive multiple sclerosis. Eur J Neurol. 2021; https:\/\/doi.org\/10.1111\/ene.15056.","journal-title":"Eur J Neurol"},{"key":"925_CR64","doi-asserted-by":"publisher","first-page":"e0253417","DOI":"10.1371\/journal.pone.0253417","volume":"16","author":"M Rogaczewska","year":"2021","unstructured":"Rogaczewska\u00a0M, Michalak\u00a0S, Stopa\u00a0M. Macular vessel density differs in multiple sclerosis and neuromyelitis optica spectrum disorder: an optical coherence tomography angiography study. PLoS One. 2021;16:e253417. https:\/\/doi.org\/10.1371\/journal.pone.0253417.","journal-title":"PLoS One"},{"key":"925_CR65","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/01616412.2020.1726585","volume":"42","author":"MO Ulusoy","year":"2020","unstructured":"Ulusoy\u00a0MO, Horasanl\u0131\u00a0B, I\u015f\u0131k-Ulusoy\u00a0S. Optical coherence tomography angiography findings of multiple sclerosis with or without optic neuritis. Neurol Res. 2020;42:319\u201326. https:\/\/doi.org\/10.1080\/01616412.2020.1726585.","journal-title":"Neurol Res"},{"key":"925_CR66","doi-asserted-by":"publisher","first-page":"e0243236","DOI":"10.1371\/journal.pone.0243236","volume":"15","author":"B Cordon","year":"2020","unstructured":"Cordon\u00a0B, Vilades\u00a0E, Orduna\u00a0E, et\u00a0al. Angiography with optical coherence tomography as a\u00a0biomarker in multiple sclerosis. PLoS One. 2020;15:e243236. https:\/\/doi.org\/10.1371\/journal.pone.0243236.","journal-title":"PLoS One"},{"key":"925_CR67","doi-asserted-by":"publisher","first-page":"542","DOI":"10.3389\/fneur.2020.00542","volume":"11","author":"G Cennamo","year":"2020","unstructured":"Cennamo\u00a0G, Carotenuto\u00a0A, Montorio\u00a0D, et\u00a0al. Peripapillary vessel density as early biomarker in multiple sclerosis. Front Neurol. 2020;11:542. https:\/\/doi.org\/10.3389\/fneur.2020.00542.","journal-title":"Front Neurol"},{"key":"925_CR68","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/tvst.10.6.6","volume":"10","author":"Q Chen","year":"2021","unstructured":"Chen\u00a0Q, Jiang\u00a0H, Delgado\u00a0S, et al. Longitudinal study of retinal structure, vascular, and neuronal function in patients with relapsing-remitting multiple sclerosis: 1\u2011year follow-up. Transl Vis Sci Technol. 2021;10:6. https:\/\/doi.org\/10.1167\/tvst.10.6.6.","journal-title":"Transl Vis Sci Technol"},{"key":"925_CR69","doi-asserted-by":"publisher","first-page":"618879","DOI":"10.3389\/fneur.2020.618879","volume":"11","author":"OC Murphy","year":"2020","unstructured":"Murphy\u00a0OC, Kalaitzidis\u00a0G, Vasileiou\u00a0E, et\u00a0al. Optical coherence tomography and optical coherence tomography angiography findings after optic neuritis in multiple sclerosis. Front Neurol. 2020;11:618879. https:\/\/doi.org\/10.3389\/fneur.2020.618879.","journal-title":"Front Neurol"},{"key":"925_CR70","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.4103\/ijo.IJO_2964_20","volume":"69","author":"SA Khader","year":"2021","unstructured":"Khader\u00a0SA, Nawar\u00a0AE, Ghali\u00a0AA, et\u00a0al. Evaluation of optical coherence tomography angiography findings in patients with multiple sclerosis. Indian J Ophthalmol. 2021;69:1457\u201363. https:\/\/doi.org\/10.4103\/ijo.IJO_2964_20.","journal-title":"Indian J Ophthalmol"},{"key":"925_CR71","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ajo.2019.12.021","volume":"213","author":"H Jiang","year":"2020","unstructured":"Jiang\u00a0H, Gameiro\u00a0GR, Liu\u00a0Y, et\u00a0al. Visual function and disability are associated with increased retinal volumetric vessel density in patients with multiple sclerosis. Am J Ophthalmol. 2020;213:34\u201345. https:\/\/doi.org\/10.1016\/j.ajo.2019.12.021.","journal-title":"Am J Ophthalmol"},{"key":"925_CR72","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41433-019-0746-y","volume":"34","author":"H Yilmaz","year":"2020","unstructured":"Yilmaz\u00a0H, Ersoy\u00a0A, Icel\u00a0E. Assessments of vessel density and foveal avascular zone metrics in multiple sclerosis: an optical coherence tomography angiography study. Eye (Lond). 2020;34:771\u20138. https:\/\/doi.org\/10.1038\/s41433-019-0746-y.","journal-title":"Eye (Lond)"},{"key":"925_CR73","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.msard.2016.06.001","volume":"9","author":"E Fogarty","year":"2016","unstructured":"Fogarty\u00a0E, Schmitz\u00a0S, Tubridy\u00a0N, et al. Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: systematic review and network meta-analysis. Mult Scler Relat Disord. 2016;9:23\u201330. https:\/\/doi.org\/10.1016\/j.msard.2016.06.001.","journal-title":"Mult Scler Relat Disord"},{"key":"925_CR74","doi-asserted-by":"publisher","first-page":"102125","DOI":"10.1016\/j.msard.2020.102125","volume":"42","author":"LY Goh","year":"2020","unstructured":"Goh\u00a0LY, Kirthi\u00a0V, Silber\u00a0E, et al. Real-world incidence of fingolimod-associated macular oedema. Mult Scler Relat Disord. 2020;42:102125. https:\/\/doi.org\/10.1016\/j.msard.2020.102125.","journal-title":"Mult Scler Relat Disord"},{"key":"925_CR75","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/bcpt.13381","volume":"126","author":"TL N\u00f8rgaard","year":"2020","unstructured":"N\u00f8rgaard\u00a0TL, Andersen\u00a0CU, Hilt\u00a0C, et\u00a0al. Macular oedema and changes in macular thickness in multiple sclerosis patients treated with fingolimod. Basic Clin Pharmacol Toxicol. 2020;126:492\u20137. https:\/\/doi.org\/10.1111\/bcpt.13381.","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"925_CR76","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s10072-020-04802-x","volume":"42","author":"A d\u2019Ambrosio","year":"2021","unstructured":"d\u2019Ambrosio\u00a0A, Capuano\u00a0R, Rossi\u00a0S, et al. Two-year macular volume assessment in multiple sclerosis patients treated with fingolimod. Neurol Sci. 2021;42:731\u20133. https:\/\/doi.org\/10.1007\/s10072-020-04802-x.","journal-title":"Neurol Sci"},{"key":"925_CR77","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/wno.0000000000000802","volume":"40","author":"JK Chan","year":"2020","unstructured":"Chan\u00a0JK, Hernandez Mart\u00ednez de Lapiscina\u00a0E, Taylor\u00a0C, et al. Long-term stability of neuroaxonal structure in alemtuzumab-treated relapsing-remitting multiple sclerosis patients. J\u00a0Neuroophthalmol. 2020;40:37\u201343. https:\/\/doi.org\/10.1097\/wno.0000000000000802.","journal-title":"J Neuroophthalmol"},{"key":"925_CR78","doi-asserted-by":"publisher","first-page":"e2525","DOI":"10.1212\/wnl.0000000000011933","volume":"96","author":"J Lambe","year":"2021","unstructured":"Lambe\u00a0J, Risher\u00a0H, Filippatou\u00a0AG, et\u00a0al. Modulation of retinal atrophy with rituximab in multiple sclerosis. Neurology. 2021;96:e2525\u2013e33. https:\/\/doi.org\/10.1212\/wnl.0000000000011933.","journal-title":"Neurology"},{"key":"925_CR79","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1093\/brain\/awaa333","volume":"143","author":"P Petrou","year":"2020","unstructured":"Petrou\u00a0P, Kassis\u00a0I, Levin\u00a0N, et\u00a0al. Beneficial effects of autologous mesenchymal stem cell transplantation in active progressive multiple sclerosis. Brain. 2020;143:3574\u201388. https:\/\/doi.org\/10.1093\/brain\/awaa333.","journal-title":"Brain"},{"key":"925_CR80","doi-asserted-by":"publisher","first-page":"615790","DOI":"10.3389\/fneur.2021.615790","volume":"12","author":"K Klumbies","year":"2021","unstructured":"Klumbies\u00a0K, Rust\u00a0R, D\u00f6rr\u00a0J, et\u00a0al. Retinal thickness analysis in progressive multiple sclerosis patients treated with epigallocatechin gallate: optical coherence tomography results from the SUPREMES study. Front Neurol. 2021;12:615790. https:\/\/doi.org\/10.3389\/fneur.2021.615790.","journal-title":"Front Neurol"},{"key":"925_CR81","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1007\/s10072-020-04360-2","volume":"41","author":"S Yadegari","year":"2020","unstructured":"Yadegari\u00a0S, Gholizade\u00a0A, Ghahvehchian\u00a0H, et\u00a0al. Effect of phenytoin on retinal ganglion cells in acute isolated optic neuritis. Neurol Sci. 2020;41:2477\u201383. https:\/\/doi.org\/10.1007\/s10072-020-04360-2.","journal-title":"Neurol Sci"},{"key":"925_CR82","doi-asserted-by":"publisher","first-page":"105741","DOI":"10.1016\/j.clineuro.2020.105741","volume":"193","author":"M Moghaddasi","year":"2020","unstructured":"Moghaddasi\u00a0M, Nabovvati\u00a0M, Koushki\u00a0A, et\u00a0al. Randomized control trial of evaluation of clemastine effects on visual evoked potential, nerve fiber layer and ganglion cell layer complex in patients with optic neuritis. Clin Neurol Neurosurg. 2020;193:105741. https:\/\/doi.org\/10.1016\/j.clineuro.2020.105741.","journal-title":"Clin Neurol Neurosurg"},{"key":"925_CR83","doi-asserted-by":"publisher","DOI":"10.1177\/1352458520964409","author":"RA Bermel","year":"2020","unstructured":"Bermel\u00a0RA, Fedler\u00a0JK, Kaiser\u00a0P, et al. Optical coherence tomography outcomes from SPRINT-MS, a\u00a0multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosis. Mult Scler. 2020; https:\/\/doi.org\/10.1177\/1352458520964409.","journal-title":"Mult Scler"},{"key":"925_CR84","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/brain\/awaa062","volume":"143","author":"M Dietrich","year":"2020","unstructured":"Dietrich\u00a0M, Koska\u00a0V, Hecker\u00a0C, et al. Protective effects of 4\u2011aminopyridine in experimental optic neuritis and multiple sclerosis. Brain. 2020;143:1127\u201342. https:\/\/doi.org\/10.1093\/brain\/awaa062.","journal-title":"Brain"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-022-00925-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10354-022-00925-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-022-00925-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T15:44:39Z","timestamp":1666799079000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10354-022-00925-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,28]]},"references-count":84,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["925"],"URL":"https:\/\/doi.org\/10.1007\/s10354-022-00925-2","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,28]]},"assertion":[{"value":"6 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.\u00a0Olbert and W.\u00a0Struhal declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}